Syros Pharmaceuticals, Inc. (SYRS) Stock Overview
OTC Pink · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined…
Source: Yahoo Finance
Sector & Industry
Syros Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the OTC Pink exchange.
Syros Pharmaceuticals, Inc. at a Glance
| Company | Syros Pharmaceuticals, Inc. |
| Ticker | SYRS |
| Exchange | OTC Pink |
| Currency | USD |
| Price | $0.00 |
| Market cap | $10,732 |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.07 |
| 52-week high | $0.02 |
| 52-week low | $0.00 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.73 |
| Return on equity (ROE) | -776.96% |
| Debt-to-equity | — |
| Average volume | 11,464 |
| Shares outstanding | 26.83M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 68 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Syros Pharmaceuticals, Inc.'s current P/E ratio?
- Syros Pharmaceuticals, Inc. (SYRS) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Syros Pharmaceuticals, Inc.'s market capitalisation?
- Syros Pharmaceuticals, Inc.'s market cap is $10,732 based on our latest snapshot. See how it ranks by market cap →
- What is SYRS's 52-week range?
- Over the past 52 weeks, SYRS has traded between $0.00 and $0.02. What does the 52-week range mean? →
- How volatile is Syros Pharmaceuticals, Inc. compared to the market?
- Syros Pharmaceuticals, Inc. has a beta of 1.73, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Syros Pharmaceuticals, Inc. pay a dividend?
- Syros Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is SYRS listed on?
- SYRS is listed on the OTC Pink. Browse all OTC Pink-listed stocks →
- What sector is Syros Pharmaceuticals, Inc. in?
- Syros Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →